Contact
Please use this form to send email to PR contact of this press release:
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages BioXcel Therapeutics (BTAI) Investors with Substantial Losses to Contact Firm’s Attorney, Securities Fraud Class Action Filed
TO: